A Phase IIb Randomised Controlled Trial of Continuous Beta-Lactam Infusion Compared With Intermittent Beta-Lactam Dosing in Critically Ill Patients With Severe Sepsis (2012-2017)
Experts
Emeritus Professor
Jeffrey Lipman
Emeritus/Emerita/Emeritx Professor
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
